Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

6 Apr 2022 13:45

RNS Number : 5101H
Maven Income and Growth VCT 3 PLC
06 April 2022
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 1-2 Royal Exchange Buildings, London EC3V 3LF on Wednesday 6 April 2022 at 12.30 pm, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 4 April 2022, the total number of voting rights in the Company stood at and the total shares in issue were 96,818,862. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 5,863,341 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

5,587,410

253,561

4,956

17,414

5,863,341

2

To approve the Directors' Remuneration Report

4,895,280

301,780

616,094

50,187

5,863,341

3

To approve a final dividend payment

5,605,577

251,662

6,102

0

5,863,341

4

To re-elect Atul Devani as a Director

5,462,785

253,561

75,435

71,560

5,863,341

5

To re-elect David Allan as a Director

5,479,977

253,561

20,562

109,241

5,863,341

6

To re-elect Bill Nixon as a Director

5,200,640

253,561

76,127

333,013

5,863,341

7

To re-elect Keith Pickering as a Director

5,271,989

253,561

270,772

67,019

5,863,341

8

To re-appoint Deloitte LLP as Auditor

4,667,398

310,268

817,388

68,287

5,863,341

9

To authorise the Directors to fix the remuneration of the Auditor

5,239,763

400,163

182,997

40,418

5,863,341

10

To authorise the Directors to allot new shares

5,014,051

242,697

556,346

50,247

5,863,341

11

To authorise disapplication of pre-emption rights

4,736,240

265,172

764,512

97,417

5,863,341

12

To authorise the Company to purchase its own shares

4,857,471

240,482

729,511

35,877

5,863,341

13

To allow a General Meeting to be called on not less than 14 days' notice

5,368,572

240,482

235,692

18,595

5,863,341

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2022 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

6 April 2022

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKABQBBKDBQK
Date   Source Headline
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
26th Jul 201911:25 amRNSHalf-year Report
10th Jul 20195:03 pmRNSTransaction in Own Shares
2nd Jul 20194:20 pmRNSUnaudited Net Asset Value and Interim Dividend
28th May 20193:13 pmRNSTransaction in Own Shares
11th Apr 201910:53 amRNSNet Asset Value(s)
10th Apr 201912:49 pmRNSResult of AGM
1st Mar 20193:01 pmRNSAnnual Financial Report
7th Feb 20194:34 pmRNSTransaction in Own Shares
17th Jan 20193:06 pmRNSNet Asset Value(s)
27th Nov 20182:42 pmRNSTransaction in Own Shares
21st Nov 20184:03 pmRNSNet Asset Value(s)
20th Jul 20184:04 pmRNSHalf-year Report
17th Jul 20184:09 pmRNSTransaction in Own Shares
3rd Jul 20184:30 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:49 pmRNSStatement re DIS
17th May 20184:30 pmRNSDividend Declaration
26th Apr 20189:35 amRNSDirector/PDMR Shareholding
24th Apr 20184:51 pmRNSIssue of Equity
16th Apr 20185:12 pmRNSNet Asset Value(s)
13th Apr 201812:47 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
11th Apr 20181:12 pmRNSResult of AGM
6th Apr 20184:38 pmRNSStatement re Dividend Investment Scheme
6th Apr 20189:21 amRNSDirector/PDMR Shareholding
5th Apr 20186:22 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.